Skip to main content
Ethnic and racial differences in patients with Ewing sarcoma.
Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.